
BD-Taxel 30 Injection
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Paclitaxel (30mg)
Overview BD-Taxel 30 Injection
Taxel-BD 30 Injection is a chemotherapy drug indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Benefits may not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include nausea, vomiting, and fatigue; serious side effects can include edema (swelling of hands/face), alopecia (hair loss), and weight gain. Your doctor may prescribe additional medication to mitigate these. Report any unusual bruising/bleeding, sore throat, mouth sores, or fever immediately. This medication can decrease blood cell counts, raising infection risk. Regular blood tests monitoring blood cell levels and liver function are necessary. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or current infection treatments before starting this medication. It can interact with other medications; disclose all current medications to your doctor. This medicine is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners during treatment.
Uses of BD-Taxel 30 Injection
Cancers of the breast, lung (non-small cell type), and pancreas
Major Benefits of BD-Taxel 30 Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of BD-Taxel 30 Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use BD-Taxel 30 Injection:
Administering this medication will be performed by your healthcare provider; self-medication is strictly prohibited.
How BD-Taxel 30 Injection works:
Taxel 30 BD injection is a cancer treatment that disrupts microtubules, essential components of cancer cell division. This disruption inhibits cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with BD-Taxel 30 Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using BD-Taxel 30 Injection during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of BD-Taxel 30 Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate the drug may harm the nursing infant.
DrivingUNSAFE
Driving ability may be impaired by BD-Taxel 30 Injection side effects. While driving between treatment cycles isn't prohibited, the injection's alcohol content suggests caution regarding driving.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely receive BD-Taxel 30 Injection without a recommended dosage change. Nevertheless, consultation with a physician is advised if kidney impairment exists.
LiverCAUTION
Patients with liver impairment should receive BD-Taxel 30 Injection cautiously, potentially requiring dose modification. Consult your physician. BD-Taxel 30 Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take BD-Taxel 30 Injection :
NA
Facts to Know About BD-Taxel 30 Injection
| Label | Value |
|---|---|
| Type of Compound | Taxane-based agents |
| Potential for Dependence | None. |
| Type of Treatment | Cancer therapeutics |
| Mechanism of Action | Microtubule-disrupting drugs: Taxane class |
